Access to Treatment

We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

The Global CEO Initiative on Alzheimer's Disease (CEOi)

  • Connecting the Alzheimer's community as partners in research

  • Patient and caregiver-led collaboration to understand what matters most